2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 63, n° 5
pages e102-e104 (novembre 2010)
Doi : 10.1016/j.jaad.2010.02.030
JAAD Online

Imatinib treatment of generalized localized scleroderma (morphea)

Pia Moinzadeh, MD , Thomas Krieg, MD, FRCP, Nicolas Hunzelmann, MD
Department for Dermatology and Venerology, University of Cologne, Cologne, Germany 

Correspondence to: Pia Moinzadeh, MD, Klinik und Poliklinik für Dermatologie und Venerologie, Klinikum der Universität zu Köln, Kerpener Str 62; 50924 Köln, Germany.

 Imatinib provided by Novartis.
 Conflicts of interest: None declared.

Top of the page

© 2010  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline